Eaton Vance Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-29,579
| Closed | -$424K | – | 1792 |
|
|
2022
Q1 | $424K | Sell |
29,579
-13,508
| -31% | -$194K | ﹤0.01% | 1557 |
|
|
2021
Q4 | $586K | Buy |
43,087
+1,830
| +4% | +$24.9K | ﹤0.01% | 1296 |
|
|
2021
Q3 | $585K | Sell |
41,257
-13,096
| -24% | -$186K | ﹤0.01% | 1190 |
|
|
2021
Q2 | $915K | Sell |
54,353
-7,724
| -12% | -$130K | ﹤0.01% | 1210 |
|
|
2021
Q1 | $1.13M | Sell |
62,077
-1,898
| -3% | -$34.7K | ﹤0.01% | 1108 |
|
|
2020
Q4 | $1.17M | Buy |
63,975
+7,421
| +13% | +$135K | ﹤0.01% | 1043 |
|
|
2020
Q3 | $1.01M | Buy |
56,554
+2,950
| +6% | +$52.6K | ﹤0.01% | 982 |
|
|
2020
Q2 | $961K | Buy |
53,604
+589
| +1% | +$10.6K | ﹤0.01% | 972 |
|
|
2020
Q1 | $811K | Buy |
53,015
+89
| +0.2% | +$1.36K | ﹤0.01% | 965 |
|
|
2019
Q4 | $1.04M | Buy |
52,926
+4,601
| +10% | +$90.7K | ﹤0.01% | 980 |
|
|
2019
Q3 | $831K | Buy |
48,325
+1,231
| +3% | +$21.2K | ﹤0.01% | 1015 |
|
|
2019
Q2 | $834K | Sell |
47,094
-10,245
| -18% | -$181K | ﹤0.01% | 1003 |
|
|
2019
Q1 | $1.17M | Buy |
+57,339
| New | +$1.17M | ﹤0.01% | 880 |
|